 |
Conny Bogentoft
CEO
Ph.D in Medicinal Chemistry, Associate Professor in Pharmaceutical
Chemistry. Has, with more than 30 years' experience of pharmaceutical
industry, as senior R&D management positions and as a member
of board of directors for a number of companies, demonstrated
his ability to successfully plan, implement and develop clinical
and business strategies. Previous appointments include Vice
President of Astra Arcus, President of Kabi Invent, Research
Director at Aco Läkemedel, and Chairman of the Swedish
Academy of Pharmaceutical Sciences.
Number of shares held in Karolinska Development AB: 29 433. |
